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ABSTRACT 
This study seeks to establish the normal serum concentrations of biochemical markers related to nutrition, inflammation 
and disease, and to investigate how the levels change with age and diet in the rat. To this end, we fed rats from weaning 
on three diets differing in their protein, carbohydrate and fatty acid content. The diets consisted of a control, nutrition- 
ally balanced diet, this same diet supplemented with 10% (wt/wt) beef tallow, and a diet that was high in fat and car- 
bohydrate and low in protein. Blood samples from rats at two different ages, 3 months and 12 months, were then ana- 
lysed. In control rats, with advancing age there was a general decrease in potassium, iron and serum albumin concen- 
trations and in the activities of aspartate aminotransferase and alanine aminotransferase, and an increase in total and 
HDL cholesterol. These changes were modulated by diet: many of the age-related changes (serum concentrations of 
potassium, iron and cholesterol, and liver enzyme activities) were not observed in animals eating the high fat diet. In 
contrast, the high carbohydrate, high fat, low protein diet-fed animals showed several additional changes (serum con- 
centrations of sodium, urea, creatinine and TG, and activity of alkaline phosphatase) that can be related to kidney, liver 
and cardiovascular health. 
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1. Introduction 
Ageing is a complex process, involving gradual changes 
in the functioning of many body systems, and ultimately 
leading to irreversible loss of viability. There is consid-
erable interest in identifying causative mechanisms in- 
volved in ageing, with a view to finding interventions 
that will reverse if not all, then at least the most debili- 
tating losses of function, thereby maximising quality of 
life. It is relatively straightforward to identify failing pro- 
cesses in elderly animals and humans; much less evident 
are early changes marking the onset of such failures be- 
fore clinical signs become apparent [1]. Here we have 
used a rat model to identify such early changes by study- 
ing parameters associated with particular clinical condi- 
tions in animals of two ages. We have investigated whether, 
in line with previous suggestions [2], the parameters can 
be affected by diet and might therefore be amenable to 
modulation by dietary components, leading to therapeutic 
benefit.  
Besides a generalised loss of function in many body sys- 
tems, ageing is frequently accompanied by the development 
of a pro-inflammatory state in which circulating levels of 
pro-inflammatory cytokines, particularly IL-6, are eleva- 
ted [3]. This state has been referred to as inflammaging 
[4]. Prolonged inflammation has been associated with 
several debilitating conditions such as inflammatory 
bowel disease, rheumatoid arthritis, neurodegenerative 
diseases and cardiovascular disease [5,6]. 
We and others have previously shown that immune 
responses, including inflammation, can be modulated by 
diet [7-10]. Moreover there is a large body of literature 
relating to the effects of diet on various parameters of 
health, particularly cardiovascular disease [11]. Our   
hypothesis is that the biomarkers shown in this study to 
change with age can be modulated by different diets.  
To investigate changes in diagnostic parameters over 
time we used rats aged 3 months (young adults) and 12 
months (middle-aged). The rats were fed one of three 
diets from weaning: a nutritionally balanced rat mainte-
nance diet, this same diet supplemented with 10% wt/wt 
tallow, or a diet high in carbohydrate and fat and low in *This work was supported by The Open University. 
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protein. Blood samples were taken from the rats and tested 
for biochemical indicators of metabolic health (sodium, 
potassium, iron, transferrin, ferritin), for indicators of 
kidney (urea, creatinine) and liver (albumin, bilirubin, 
alkaline phosphatase (AP), aspartate aminotransferase 
(AST), alanine aminotransferase (ALT), γ-glutamyl tran- 
sferase (GGT)) function, for lipid profile (total choles- 
terol, triacylglycerols (TG), high density lipoprotein (HDL)- 
cholesterol, low density lipoprotein (LDL)-cholesterol) and, 
since chronic inflammation is a marker of ageing [12], for 
indicators of immune responses (C-reactive peptide (CRP), 
IL-1β, IL-6, IL-10, IFNγ and TNFα).  
2. Experimental Methods 
2.1. Animals 
Animals were male Sprague-Dawley rats, bred in-house 
and maintained in an enriched environment on a 14 h light: 
10 h dark cycle. Animals were kept and treated in accor- 
dance with the UK Animals (Scientific Procedures) Act, 
1986, and the experiments were approved by the Open 
University Animal Ethics Advisory Group. Rats were we- 
aned at three weeks of age directly onto the experimental 
or control diets which were available ad lib, and were 
maintained at three littermates per cage until the age of 12 
- 14 weeks or 12 months, when they were used. During 
this period each rat was weighed once or twice a week, 
and examined visually for signs of ill-health. Rats were 
given an Aspen Block (Lillico, UK) to gnaw, and no den- 
tal problems were experienced. The growth curves of the 
three groups of rats are shown in Figure 1. No significant 
differences were seen between them. 
2.2. Diets 
Components of the diets, previously described [13], are 
shown in Table 1. Briefly, the control diet was RM3 (Spe- 
cial Diet Services, Witham, Essex, UK). One experimental 
diet (high fat, HF) was RM3 supplemented with 10% 
wt/wt beef tallow (Atora, UK), and was rich in saturated 
fats. The second experimental diet (HFHS) was based on 
chocolate cake mix supplemented with vitamins, minerals, 
carrots and eggs; this diet was high in fat (especially satu- 
rated fats) and sugars, and low in protein. The diets were 
made up twice per week, and gas-liquid chromatographic 
analysis of the diets over a week confirmed that the fatty 
acid profiles did not deteriorate substantially over the first 
four days of storage (data not shown). 
2.3. Blood Sampling 
At the time of harvest, rats were deeply anaesthetised with 
Isofane (Novartis Animal Health UK Ltd). Approximately 4 
ml of blood was obtained by cardiac puncture. Following 
coagulation at room temperature the clots were spun down 
and the supernatants were removed and stored at –80˚C  
 
 
Figure 1. Growth curves for rats eating each of the three diets. 
Squares = control; open circles = HFHS; closed circles = HF. 
Table 1. Experimental diets used in this study. 
Constituent  Diet  
 Control High fat HFHS 
Energy kJ/100g 1530 1699 1513 
Protein g/100g 22.3 20.4 7.3 
Protein: energy 14.6 12 4.8 
43.5 40.4 38.9 Carbohydrate g/100g 
Sugars 7.7 7.0 22.7 
Fat g/100g 4.3 11.8 9.8 
SFA 0.7 4.9 3.1 
MUFA 1.24 3.8 2.9 
PUFA 1.74 1.69 2.5 
U:S 4.26 1.12 1.74 
Fibre g/100g 12.2 11.1 1.6 
Vitamins and minerals g/100g 2.5 2.3 2.8 
 
until analysis. Following cardiac bleeding, the rats were 
killed by intracardiac injection of Pentoject (Animal Care 
Ltd, UK). 
2.4. Biochemical Analyses 
Serum metabolites, electrolytes, renal profile, liver func- 
tion and lipid profile were analysed using a Cobas In- 
tegra 800 analyser (Roche Diagnostics, Mannheim, Ger- 
many). Nine animals under each condition were tested 
for every analyte. Sera from the same animals were also 
used in triplicate in ELISAs to determine circulating lev- 
els of IL-1β, IL-6, IL-10, IFNγ and TNFα. All ELISA 
assays were carried out using kits purchased from R&D 
Systems Ltd, Abingdon, UK. 
Analytes and their clinical relevance are shown in Table 2. 
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2.5. Statistical Analyses 
Since the rats were kept at three per cage, and nine indi-
viduals were used for each treatment (three cages), the ex- 
perimental unit was three for each of four treatments (three 
diets and one age difference). According to Mead’s re- 
source equation [14], this gives an E value of 14, meaning 
that the numbers of animals used are appropriate to give 
robust data. All data are expressed as mean ± SEM. Dif- 
ferences between means were assessed by ANOVAs and 
t-tests as appropriate, using Prism v5 (GraphPad Software, 
San Diego, California, USA, www.graphpad.com). ANO- 
VAs were validated by using Bartlett’s test for equality of 
variances. Differences were considered statistically sig- 
nificant at the P < 0.05 level. 
3. Results 
3.1. Individual Differences 
ANOVA confirmed that there were no significant differ- 
ences in the analyte patterns between individuals in the 
same treatment cohort (data not shown). 
Levels of analytes were compared between three  
month and 12-month animals eating each diet. The re-
sults are shown in Tables 3-7. Changes with age in ani-
mals eating a normal diet are shown in columns 2 and 3 
in all these Tables. The effects of diet can be seen in 
columns 5 and 6 for the HF diet, and columns 8 and 9 for 
the HFHS diet. 
3.2. Changes with Age 
Table 3 shows the normal pattern of change in electro- 
lyte levels with age (columns 2 and 3). Sodium, transfer- 
rin and ferritin do not change over the time period stud- 
ied; however potassium and iron levels fall with age.  
Table 4 shows the values for markers of kidney func- 
tion. There are no significant changes over this time pe- 
riod in animals eating a control diet. 
Table 5 shows the values for markers of liver function. 
There are no changes in bilirubin, alkaline phosphatase 
or GGT values; however AST and ALT both show sig- 
nificantly decreased activity over the time period studied.  
Table 6 shows the values of blood lipid levels. There is 
no significant change in LDL-cholesterol; however HDL- 
cholesterol, and hence total cholesterol, values were signify- 
cantly increased over this time period in control animals. 
Table 7 shows the values for markers of immune func-
tion, used as proxies for inflammaging. No differences 
were seen either with age or diet in these animals. 
3.3. Baseline Values in Animals Eating Experimental 
Diets 
Considering the HF diet, baseline values were similar to 
the control diet values for all the analytes except for the  
concentration of serum potassium and the activities of 
AST and ALT, which were lower in animals eating the 
experimental diet, and the concentrations of sodium and 
TG, and the activity of alkaline phosphatase, which were 
higher with the experimental diet (Tables 3, 5 and 6). 
Baseline values of all types of serum cholesterol were 
unchanged (Table 6). 
Considering the HFHS diet, baseline serum concentra-
tions of potassium, iron and urea, and the activities of 
AST and ALT were lower than with the control diet, 
while the concentrations of sodium, LDL cholesterol and 
TG, and the activity of alkaline phosphatase were higher 
(Tables 3-6). Other analytes showed values similar to 
those found in animals eating the control diet. 
3.4. Changes with Age in Animals Eating the 
Experimental Diets 
In animals eating the HF diet, only one analyte showed a 
significant change that was not observed in control ani- 
mals: the activity of alkaline phosphatase decreased be- 
tween the ages of 3 and 12 months. The decreases ob- 
served in control animals in the concentration of albumin 
and in the AST: ALT ratio were also seen in the HF ani- 
mals, but none of the other changes seen in control ani- 
mals were reproduced in animals eating this diet. 
In animals eating the HFHS diet there were a number 
of similarities with values obtained from animals eating 
the control diet, in particular the decrease observed in the 
serum concentration of potassium and the increase in 
total and HDL-cholesterol. A number of differences were 
also observed: there was a decrease in the activity of al-
kaline phosphatase similar to that observed in the HF rats, 
and there were increases in the concentrations of serum 
sodium, urea and creatinine that were not observed in 
animals eating either of the other diets. However, in con-
trast to the decrease seen in control animals, there was an 
increase in the activity of AST and the AST: ALT ratio. 
There was also an increase in the serum TG concentration. 
These changes are summarised in Table 8, which 
shows the analytes that were altered over time in animals 
eating the control diet, and the direction and extent of the 
changes in these analytes exhibited by ageing animals 
eating the experimental diets. 
4. Discussion 
Our results indicate that there are substantial age-related 
changes in metabolism in animals fed a nutritionally 
well-balanced diet (Tables 3-8) that can be detected 
through blood analysis at a relatively young age. We 
detected changes in markers of liver function and car-
diovascular risk factors, but no changes in markers of 
kidney or immune function. However, in animals eating   
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Table 2. Analytes investigated in this study and their clinical significance. 
Metabolic profile Kidney function Liver function Lipid profile Immune status 
Sodium Urea Albumin Total cholesterol CRP 
Potassium Creatinine Bilirubin HDL-cholesterol IL-1β 
Iron  AP LDL-cholesterol IL-6 
Transferrin  AST TG IL-10 
Ferritin  ALT  IFNγ 
  GGT  TNFα 
 
Table 3. Levels of analytes denoting general metabolic condition in rats of two ages eating one of three diets.1 
     Diet     
Analyte / unit Control 3 month 
Control 12 
month Change
High fat 3 
month 
High fat 12 
month Change
HFHS 3 
month 
HFHS 12 
month Change
Sodium / 
mmol·l–1 111.0 ± 9.02 134.0 ± 5.89 n.s. 132.3 ± 4.62 134.1 ± 1.65 n.s. 130.3 ± 2.13 146.2 ± 0.83 Inc ***
Potassium / 
mmol·l–1 35.13 ± 2.75 14.2 ± 0.9 Dec** 13.9 ± 1.25 15.23 ± 0.34 n.s. 10.77 ± 0.13 5.87 ± 0.12 Dec***
Iron/mmol·l–1 44.67 ± 1.86 27.33 ± 1.33 Dec** 50.33 ± 2.9 37.67 ± 2.85 n.s. 26.0 ± 1.53 31.3 ± 3.8 n.s. 
Transferrin/ 
mmol·l–1 ND 0.89 ± 0.1 n.s. ND ND n.s. ND ND n.s. 
Ferritin/μg·l–1 ND ND n.s. ND ND n.s. ND ND n.s. 
1Data are means ± SEM. The direction of change is indicated: Inc = increase, Dec = decrease; ND = not detectable; asterisks show within-diet significance at 
the **P < 0.01 and ***P < 0.001 levels; n.s., no significant change. 
 
Table 4. Markers of kidney function in rats of two ages eating one of three diets.1 
     Diet     
Analyte/unit Control 3 month 
Control 12 
month 
Change
 
High fat 3 
month 
High fat 12 
month 
Change
 
HFHS 3 
month 
HFHS 12 
month 
Change
 
Urea/ mmol·l–1 7.67 ± 0.74 7.84 ± 0.39 n.s. 6.85 ± 0.65 6.92 ± 0.23 n.s. 3.26 ± 0.19 4.31 ± 0.26 Inc** 
Creatinine/ 
mmol·l–1 37.0 ± 14.1 37.7 ± 5.04 n.s. 33.3 ± 5.78 25.3 ± 0.67 n.s. 31.67 ± 1.2 50.33 ± 2.4 Inc** 
1Data are means ± SEM. The direction of change is indicated: Inc = increase; asterisks show within-diet significance at the **P < 0.01 level; n.s., no significant change. 
 
Table 5. Measured levels of liver function in rats of two ages eating one of three diets.1 
Analyte/unit Control 3 month 
Control 12 
month Change
High fat 3 
month 
High fat 12 
month Change
HFHS 3 
month 
HFHS 12 
month Change
Albumin/μg·l–1 33.67 ± 2.03 27.78 ± 1.06 Dec* 37.67 ± 1.49 33.0 ± 1.27 Dec* 37.67 ± 1.38 38.89 ± 0.77 n.s. 
Bilirubin/μmol·l–1 2.0 ± 0 1.0 ± 0 n.s. 1.33 ± 0.17 1.11 ± 0.11 n.s. 1.0 ± 0 1.56 ± 0.18 n.s. 
AP / IU·l–1 91.0 ± 12.17 104.33 ± 9.4 n.s. 198.3 ± 22.5 119.3 ± 3.1 Dec* 157.0 ± 8.3 103.3 ± 10.4 Dec* 
AST / IU·l–1 351.0 ± 24.27 108.7 ± 21.88 Dec** 210.0 ± 32.1 126.7 ± 6.9 n.s. 99.7 ± 14.3 228.7 ± 10.3 Inc** 
ALT / IU·l–1 117.3 ± 3.71 79.67 ± 0.33 Dec*** 84.3 ± 8.1 105.7 ± 6.3 n.s. 46.0 ± 7.6 38.0 ± 6.2 n.s. 
AST:ALT 2.99 ± 0.17 1.36 ± 0.27 Dec** 2.52 ± 0.46 1.2 ± 0.01 Dec* 3.32 ± 0.6 6.26 ± 0.74 Inc* 
GGT / IU·l–1 1.0 ± 0 0.89 ± 0.11 n.s. 1.0 ± 0 1.0 ± 0 n.s. 1.0 ± 0 1.0 ± 0 n.s. 
1Data are means ± SEM. The direction of change is indicated: Inc = increase, Dec = decrease; asterisks show within-diet significance at the *P < 0.05, **P < 
0.01 and ***P < 0.001 levels; n.s., no significant change. 
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Table 6. Levels of blood lipid markers of cardiovascular risk in rats of two ages eating one of three diets.1 
     Diet     
Analyte/unit Control 3 month 
Control 12 
month Change
High fat 3 
month 
High fat 12 
month Change
HFHS 3 
month 
HFHS 12 
month Change
Total cholesterol/ 
mmol·l–1 3.03 ± 0.37 7.03 ± 1.18 Inc* 3.4 ± 0.45 6.1 ± 1.35 n.s. 2.77 ± 0.12 3.93 ± 0.39 Inc* 
HDL-cholesterol/ 
mmol·l–1 2.2 ± 0.27 4.2 ± 0.06 Inc** 2.3 ± 0.35 3.43 ± 0.29 n.s. 1.37 ± 0.07 2.23 ± 0.03 Inc***
LDL-cholesterol/ 
mmol·l–1 0.4 ± 0.11 1.23 ± 0.62 n.s. 0.45 ± 0.15 1.53 ± 0.64 n.s. 0.73 ± 0.03 0.8 ± 0.5 n.s. 
TG/mmol·l–1 0.91 ± 0.06 3.52 ± 1.59 n.s. 2.52 ± 1.13 2.53 ± 0.99 n.s. 1.43 ± 0.08 2.74 ± 0.15 Inc** 
1Data are means ± SEM. The direction of change is indicated: Inc = increase; asterisks show within-diet significance at the *P < 0.05, **P < 0.01 and ***P < 
0.001 levels; n.s., no significant change. 
 
Table 7. Levels of markers of inflammation in rats of two ages eating one of three diets.1 
         Diet     
Analyte/unit Control 3 month 
Control 12 
month Change
High fat 3 
month 
High fat 12 
month Change
HFHS 3 
month 
HFHS 12 
month Change
CRP/mg·l–1 ND ND n.s. ND ND n.s. ND ND n.s. 
IL-1β/pg·ml–1 149.9 ± 0.59 126.7 ± 0.25 n.s. 149.9 ± 1.65 121.7 ± 0.73 n.s. 174.9 ± 6.12 139.2 ± 1.53 n.s. 
IL-6/pg·ml–1 342.9 ± 8.91 314.3 ± 1.26 n.s. 316.5 ± 2.85 305.5 ± 0.92 n.s. 305.5 ± 1.83 305.5 ± 0.61 n.s. 
IL-10/pg·ml–1 194.1 ± 5.24 239.9 ± 11.9 n.s. 156.1 ± 1.4 166.8 ± 0.83 n.s. 150.2 ± 0.9 159.0 ± 0.48 n.s. 
IFNγ/pg·ml–1 163.0 ± 24.5 154.5 ± 25.9 n.s. 145.5 ± 1.45 145.5 ± 0.58 n.s. 145.5 ± 1.45 160.9 ± 1.6 n.s. 
TNFα/pg·ml–1 92.5 ± 1.02 85.9 ± 0.6 n.s. 96.7 ± 1.16 97.9 ± 2.25 n.s. 97.3 ± 2.63 85.4 ± 0.59 n.s. 
1Data are means ± SEM; ND = not detectable; n.s., no significant change. 
 
Table 8. Modulation by diet of age-related changes in analyte concentrations. Analytes listed are those which showed signifi-
cant changes with age in animals eating the control diet; the direction of change is indicated. n.s., no significant change. 
Analyte changed in control diet Change in High Fat diet Change in HFHS diet 
Potassium decreased n.s. Decreased 
Iron decreased n.s. n.s. 
Albumin decreased Decreased n.s. 
AST decreased n.s. Increased 
ALT decreased n.s. n.s. 
Total cholesterol increased n.s. Increased 
HDL-cholesterol increased n.s. Increased 
 
sub-optimal diets there are a number of deviations from 
this pattern, and in animals eating a HFHS diet, there is 
also evidence of impairment of kidney function. 
Considering first the blood electrolytes, it is notable 
that although there is a non-significant trend upwards in 
sodium concentration, there is a significant decrease in po- 
tassium with age. Interestingly, although sodium and potas- 
sium are regulated together so that a correct electrolyte 
balance is maintained, low potassium has been linked to 
high blood pressure, independently of high sodium [15,16]. 
Indeed it has been reported that raising potassium levels 
by dietary supplementation with potassium alginate can 
reduce hypertension in rats [17]. The decrease in potas- 
sium was not seen in animals eating the HF diet; nor did 
these rats show any increase in sodium levels. However, 
animals eating the HFHS diet showed highly significant 
Copyright © 2011 SciRes.                                                                                  FNS 
Age-Related Biomarkers Can Be Modulated by Diet in the Rat 889 
differences in both potassium (decreased) and sodium 
(increased), indicating that these animals are at increased 
risk of hypertension. This is in line with findings from a 
large body of clinical literature [16] and demonstrates the 
validity of our approach. 
Animals eating the control diet also showed a signify- 
cant decrease in serum iron concentration. There is no 
obvious reason for this, as the dietary supply is adequate 
and no iron-related health problems were observed. The 
12-month values are comparable to samples from other 
ages and diets, suggesting that the 3-month samples may 
be artificially high. Haemolysis of original samples can 
give rise to high iron and potassium values, and this may 
partially account for the high potassium levels seen in the 
three-month-old control animals (see above); however 
the highly significant decrease with age observed in HFHS- 
fed animals must have an endogenous cause as there was 
no haemolysis in these samples. Changes in iron metabo- 
lism in the context of reactions with reactive oxygen spe- 
cies have been linked to ageing and inflammation [18], 
and free iron is a risk factor for cardiovascular disease 
[19] but these reported changes relate to an increase in 
iron concentration, not a decrease as seen here. 
Turning to markers of liver function, animals eating 
the control diet showed decreases over time in the con- 
centration of albumin, and the activities of AST, ALT, 
and the AST: ALT ratio. A drop in serum albumin is a 
marker for malnutrition and inflammation [20], and the 
observation that a similar drop is also seen in animals 
eating the HF diet suggests that in this study it may be a 
marker of nutritional imbalance, particularly since in our 
study we see no signs of inflammation (see below). 
However, a decrease in albumin concentration was not 
seen in animals eating the HFHS diet, which arguably is 
less nutritionally adequate than the other two diets. The 
HF animals showed falls in AP and AST: ALT. Low 
serum alkaline phosphatase has also been associated with 
malnutrition [21], and the observation that HFHS-fed rats, 
but not control rats, also exhibit lowered levels supports 
this. Animals in every group showed changes in AST, 
ALT and the AST: ALT ratio. Notably, HFHS-fed ani- 
mals showed a significant increase in AST and in the 
AST: ALT ratio. Both these changes indicate liver dys- 
function, and this is consistent with our previous findings 
relating to liver dysfunction in animals eating a cafeteria 
diet [13]. HFHS-fed animals also showed increases in 
urea and creatinine, suggesting that their kidney function 
becomes impaired with age. 
Dyslipidaemia is associated with an increased risk of 
occlusive cardiovascular disease. Control animals show- 
ed increases in both total and HDL-cholesterol with age. 
These changes were also seen in HFHS-fed rats, which 
additionally showed raised serum TG. Interestingly, rats 
fed the HF diet did not exhibit any significant increases 
in these parameters. 
Somewhat surprisingly, given the wealth of data link- 
ing ageing with inflammation [22], we observed no dif- 
ferences in any of the measures of inflammation that we 
examined. Indeed, levels of CRP were barely detectable, 
and levels of inflammatory cytokines were uniformly low. 
It is possible that the inflammatory state associated with 
ageing is a late-onset phenomenon in the rat, and detect- 
able changes cannot be observed at the ages we studied. 
There were some significant differences between the 
diets in age-related analyte changes. Table 8 shows the 
analytes whose concentrations or activities changed with 
age in animals eating the control diet, but in addition to 
modulating these changes the experimental diets pro- 
duced additional changes. Alkaline phosphatase activities 
were elevated, and AST and ALT activities depressed in 
both experimental diets (Table 5), probably reflecting 
the metabolic changes previously described [13]. There 
were relatively few changes shown by the HF animals, 
and this may reflect the fact that they are eating the con- 
trol diet, containing the correct nutrients, plus a fat-rich 
supplement. Changes in these animals are therefore like- 
ly to reflect nutritional imbalance rather than deficiency. 
On the other hand, the HFHS-fed animals ingest a nutri- 
tionally undesirable diet that is particularly high in both 
simple carbohydrates and saturated fats and low in pro- 
tein. It is therefore not surprising that they exhibit defi- 
ciencies in kidney (evidenced by changes in serum urea 
and creatinine; Table 4) and liver (evidenced by changes 
in serum AP, AST and ALT; Table 5) function from an 
early age. These animals also exhibit lower HDL-choles- 
terol and raised TG, indicating that they are at higher risk 
of cardiovascular diseases. 
In conclusion, we have identified a number of age-re-
lated changes in blood analytes that are detectable at an 
early age, well before any clinical manifestations are evi- 
dent. These changes can be modulated by diet, and the 
wide array of changes indicative of dysfunction shown 
by HFHS-fed animals emphasises the undesirability of 
such a diet. However, it is notable that in animals eating 
the HF diet alkaline phosphatase activity is raised, but 
the ‘normal’ changes (observed in control animals) in 
levels of potassium, iron, AST, ALT, total and HDL- 
cholesterol are not seen. This observation suggests that in 
some circumstances this type of diet may alleviate some 
age-associated changes. 
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